what is tirzepatide derived from (TZP) a 39-amino acid peptide composed of both native Understand GLP-1/GIP Dual Agonist Tirzepatide

Tirzepatide is an innovative dual GIP/GLP-1 receptor agonist with the same active ingredient in Mounjaro and Zepbound, which is FDA-approved for chronic weight management in adults with obesity or who are overweight

Two things can help prevent muscle loss on semaglutide

5 The most well-known mechanism through which GLP-1RAs affect weight loss is through the endocrine pathway, but its role in the nervous system should not be overlooked

The STEP-1 trial demonstrated mean weight loss of 14.9% with semaglutide over 68 weeks, while the SURMOUNT-1 trial showed tirzepatide achieving 16-22.5% weight reduction over 72 weeks

Lancet 400 (10366), 18691881 (2022)

It is also worth noting that trial duration plays a role here